Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -75.90% is 60% above its 5-year average of -187.58%, near the high end of its 5-year range (-641.26%–-49.66%).
13.61% above its 12-month average of -87.85%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -140.73%.
NET PROFIT MARGIN
-75.90%
NET PROFIT MARGIN AVG TTM
-87.85%
NET PROFIT MARGIN AVG 3Y
-134.07%
NET PROFIT MARGIN AVG 5Y
-187.58%
NET PROFIT MARGIN AVG 10Y
-190.65%
NET PROFIT MARGIN AVG 15Y
-84.03%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+13.61%
CURRENT VS 3Y AVG
+43.39%
CURRENT VS 5Y AVG
+59.54%
CURRENT VS 10Y AVG
+60.19%
CURRENT VS 15Y AVG
+9.67%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.16%
median of 854 covered companies
CURRENT VS SECTOR MEDIAN
-47337.50%
vs the sector median at left
Xenetic Biosciences, Inc.
Market Cap
$4.94M
Net Profit Margin
-75.90%
TTM Avg
-87.85%
3Y Avg
-134.07%
5Y Avg
-187.58%
Market Cap
$4.90M
Net Profit Margin
-118.27%
TTM Avg
-13237.88%
3Y Avg
-7961.50%
5Y Avg
-5307.67%
Market Cap
$5.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.03M
Net Profit Margin
-106.78%
TTM Avg
-43.08%
3Y Avg
-12.30%
5Y Avg
-12.30%
Market Cap
$5.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1794.91%
5Y Avg
-2605.04%
Market Cap
$4.81M
Net Profit Margin
-3985.58%
TTM Avg
-1467.13%
3Y Avg
-2181.72%
5Y Avg
-1717.85%
Market Cap
$4.71M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.21M
Net Profit Margin
-612568.11%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.23M
Net Profit Margin
-4011.86%
TTM Avg
-2005.93%
3Y Avg
-2671.67%
5Y Avg
-1781.12%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | $4.94M | -75.90% | -87.85% | -134.07% | -187.58% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.90M | -118.27% | -13237.88% | -7961.50% | -5307.67% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.03M | -106.78% | -43.08% | -12.30% | -12.30% |
| Imunon, Inc. (IMNN)vs › | $5.04M | 0.00% | 0.00% | -1794.91% | -2605.04% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.81M | -3985.58% | -1467.13% | -2181.72% | -1717.85% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | -612568.11% | 0.00% | 0.00% | 0.00% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | -4011.86% | -2005.93% | -2671.67% | -1781.12% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -294.91% | -320.57% | -453.36% | -361.46% |
Operating Margin
-95.2%
Net Profit Margin
-75.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -140.73% |
| 2026-03-31 | -56.56% |
| 2025-12-31 | -75.57% |
| 2025-09-30 | -49.66% |
| 2025-06-30 | -116.75% |
| 2025-03-31 | -152.23% |
| 2024-12-31 | -162.53% |
| 2024-09-30 | -71.09% |
| 2024-06-30 | -175.38% |
| 2024-03-31 | -233.96% |
| 2023-12-31 | -174.34% |
| 2023-09-30 | -172.71% |
| 2023-06-30 | -161.44% |
| 2023-03-31 | -141.38% |
| 2022-12-31 | -304.44% |
| 2022-09-30 | -194.09% |
| 2022-06-30 | -641.26% |
| 2022-03-31 | -409.68% |
| 2021-12-31 | -553.72% |
| 2021-09-30 | -386.77% |
| 2021-06-30 | -384.79% |
| 2021-03-31 | -703.89% |
| 2020-12-31 | -792.98% |
| 2020-09-30 | -6521.27% |
| 2020-06-30 | -844.48% |
| 2020-03-31 | -2078.33% |
| 2019-12-31 | -6857.18% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 59.27% |
| 2017-09-30 | -2654.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | -13.04% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -3801.84% |
| 2013-08-31 | 946.51% |
| 2013-05-31 | -34.72% |
| 2013-02-28 | 46.32% |
| 2012-11-30 | -43.92% |
| 2012-08-31 | -162.85% |
| 2012-05-31 | -106.66% |
| 2012-02-29 | -81.36% |
| 2011-11-30 | -132.15% |
